Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for AKRX

Ticker: 
Data valid for week beginning August 30, 2010

Ticker Company Name
AKRX   [News] Akorn Inc
Company Profile
"Akorn, Inc. manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. In addition, the Company has marketed and distributed vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. The Company operates drug manufacturing facilities in Decatur, Illinois and Somerset, New Jersey. The Decatur, Illinois facilities operate as part of the Company, while the Somerset, New Jersey facility operates as Akorn (New Jersey), Inc., a wholly owned subsidiary of the Company."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

AKRX Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for AKRX. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Akorn Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $3.38
Volume Avg. 696170 shares
Industry Biotechnology and Drugs
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Stock Financials
Profit Margin .00%
Operating Margin -2.51%
Debt-to-Equity .10%
P/E ttm 0.00
EPS ttm $-0.150
Total Revenue $78,260,000
Market Cap $316,840
Annual Dividend $.00
Yield .000%
ROE 0.10%
Revenue Growth Rate Quarterly 23.80%
Earnings Growth Rate Quarterly 0.00%
Earnings Growth Rate Yearly 0.00%
Multi-Year Average Revenue Growth Rate 8.40%
Multi-Year Average Earnings Growth Rate N/A
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score  (Range: 0 to 200) Members Only


Latest News

Fri, 03 Sep 2010 02:13:17 GMTBest Performing Russell 3,000 Stocks Year to Date
Thu, 02 Sep 2010 22:34:12 GMTMarket 'Rubber Band' to Drive Up Stocks: Fifth Third's Billeadeau
Thu, 19 Aug 2010 07:11:16 GMT'New Market Wizards': Lessons From Stanley Drukenmiller
Tue, 17 Aug 2010 17:04:19 GMTAKORN INC Financials
Tue, 10 Aug 2010 18:24:00 GMTAkorn: Warming Up or Cooling Off?
Mon, 09 Aug 2010 20:34:35 GMTAKORN INC Files SEC form 10-Q, Quarterly Report
Wed, 04 Aug 2010 17:36:00 GMTBiotech Stocks: Depomed, Dendreon lead drug stocks higher
Tue, 03 Aug 2010 17:45:00 GMTBiotech Stocks: Pfizer leads drug stocks north; Akorn slides
Tue, 03 Aug 2010 17:25:00 GMTBiotech Stocks: Pfizer leads gainers; Akorn loss widens
Tue, 03 Aug 2010 14:51:00 GMTBiotech Stocks: Pfizer climbs, Akorn drops on earnings reports
Tue, 03 Aug 2010 13:00:36 GMTAKORN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Tue, 03 Aug 2010 12:00:00 GMTAkorn Reports Second Quarter 2010 Results
Tue, 03 Aug 2010 11:07:19 GMTQ2 2010 Akorn, Inc. Earnings Release - Before Market Open
Fri, 30 Jul 2010 19:05:01 GMTAKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stateme
Thu, 15 Jul 2010 12:06:38 GMTCoverage initiated on Akorn by Rodman & Renshaw
Fri, 02 Jul 2010 20:32:46 GMTAKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Thu, 01 Jul 2010 20:42:00 GMTAkorn, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call Information
Thu, 01 Jul 2010 10:00:00 GMT[video] Stocks Under $5: Two Potential Winners
Wed, 26 May 2010 10:02:58 GMTAKORN INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security
Mon, 24 May 2010 17:54:26 GMTWhat Investors Think About Akorn
News provided by Yahoo! Finance